Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019225 · ClinicalTrials.gov registry record · NA
A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 7,053
- Enrollment target
NCT02019225: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT02019225 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 7,053 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (403% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019225, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 7,053 participants
- Enrollment target
Study Summary
The purpose of the TiME Trial is to determine whether dialysis facility implementation of a minimum hemodialysis session duration of 4.25 hours (versus usual care) for patients with end-stage renal disease initiating treatment with thrice weekly maintenance hemodialysis has benefits on mortality, hospitalizations and health-related quality of life. The trial also aims to demonstrate the capacity to conduct a large, pragmatic clinical trial in partnership with two large dialysis provider organizations.
Primary Outcome
The primary outcome for the TiME Trial is time to death. The trial hypothesis is that, in comparison with the Usual Care facilities, the risk of death will be lower in the facilities randomized to the Intervention group.
Interventions
- OTHER Dialysis session of at least 4.25 hours
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,053 participants |
| Start Date | 2013-12-18 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
Why NCT02019225 stopped before completion
NCT02019225 is an interventional study that assigns participants to a tested intervention. Its 7,053 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (403% higher).
The record links to 0 conditions, and to 1 intervention - of which Dialysis session of at least 4.25 hours is the first listed.
NCT02019225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02019225 about?
NCT02019225 is a clinical study titled "A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration". The purpose of the TiME Trial is to determine whether dialysis facility implementation of a minimum hemodialysis session duration of 4.25 hours (versus usual care) for patients with end-stage renal disease initiating treatment with thrice weekly maintenance hemodialysis has benefits on mortality, ho...
What is the current status of trial NCT02019225?
This trial is currently terminated. It is a NA study. The enrollment target is 7,053 participants. The study started on 2013-12-18. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT02019225?
The interventions under investigation include: Dialysis session of at least 4.25 hours (OTHER).
Who is sponsoring clinical trial NCT02019225?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02019225's enrollment target sits among peer trials
7,053 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07106879 · 7,000 participants
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI